Clinical trials report an average of 1215% body weight reduction in patients using GLP-1 drugs like Wegovy and Mounjaro
Once peptides have been received, it is imperative that they are kept cold and away from light
Retrieved from Bliddal, M., Nohmie, G., Damkier, P., et al
Your NP reviews your specific medication and dose before treatment
[DOI] [PMC free article] [PubMed] [Google Scholar] 15.Klein SR, Hobai IA
The clinical investigators specifically noted that "gastrointestinal adverse events were partially mitigated by the use of a lower starting dose." Starting at 1 mg, which is what the Phase 3 TRIUMPH trials use, provides even more tolerability protection